The University of Southampton
University of Southampton Institutional Repository

Palliative care in liver disease: what does good look like?

Palliative care in liver disease: what does good look like?
Palliative care in liver disease: what does good look like?

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advanced disease have a symptom burden comparable to or higher than that experienced in other life-limiting illnesses. While evidence is limited, there is growing recognition that care of patients with advanced disease needs to improve. Many factors limit widespread provision of good palliative care to these patients, including the unpredictable trajectory of chronic liver disease, the misconception that palliative care and end-of-life care are synonymous, lack of confidence in prescribing and lack of time and resources. Healthcare professionals managing these patients need to develop the skills to ensure effective delivery of core palliative care, with referral to specialist palliative care services reserved for those with complex needs. Core palliative care is best delivered by the hepatology team in parallel with active disease management. This includes ensuring that discussions about disease trajectory and advance care planning occur alongside active management of disease complications. Liver disease is strongly associated with significant social, psychological and financial hardships for patients and their carers; strategies that involve the wider multidisciplinary team at an early stage in the disease trajectory help ensure proactive management of such issues. This review summarises the evidence supporting palliative care for patients with advanced chronic liver disease, presents examples of current best practice and provides pragmatic suggestions for how palliative and disease-modifying care can be run in parallel, such that patients do not miss opportunities for interventions that improve their quality of life.

2041-4137
218-227
Woodland, Hazel
aeb359be-51cb-4042-bf91-4197e15f995b
Hudson, Ben
af2f981a-46f9-4f40-bcb8-663f407b2164
Forbes, Karen
23a9e81b-6dcc-4121-a300-eb56261492d7
McCune, Anne
2798f414-04f4-46db-8f12-205084f83318
Wright, Mark
43325ef9-3459-4c75-b3bf-cf8d8dac2a21
British Association for the Study of the Liver (BASL) End of Life Special Interest Group
Woodland, Hazel
aeb359be-51cb-4042-bf91-4197e15f995b
Hudson, Ben
af2f981a-46f9-4f40-bcb8-663f407b2164
Forbes, Karen
23a9e81b-6dcc-4121-a300-eb56261492d7
McCune, Anne
2798f414-04f4-46db-8f12-205084f83318
Wright, Mark
43325ef9-3459-4c75-b3bf-cf8d8dac2a21

British Association for the Study of the Liver (BASL) End of Life Special Interest Group (2020) Palliative care in liver disease: what does good look like? Frontline Gastroenterology, 11 (3), 218-227. (doi:10.1136/flgastro-2019-101180).

Record type: Review

Abstract

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with advanced disease have a symptom burden comparable to or higher than that experienced in other life-limiting illnesses. While evidence is limited, there is growing recognition that care of patients with advanced disease needs to improve. Many factors limit widespread provision of good palliative care to these patients, including the unpredictable trajectory of chronic liver disease, the misconception that palliative care and end-of-life care are synonymous, lack of confidence in prescribing and lack of time and resources. Healthcare professionals managing these patients need to develop the skills to ensure effective delivery of core palliative care, with referral to specialist palliative care services reserved for those with complex needs. Core palliative care is best delivered by the hepatology team in parallel with active disease management. This includes ensuring that discussions about disease trajectory and advance care planning occur alongside active management of disease complications. Liver disease is strongly associated with significant social, psychological and financial hardships for patients and their carers; strategies that involve the wider multidisciplinary team at an early stage in the disease trajectory help ensure proactive management of such issues. This review summarises the evidence supporting palliative care for patients with advanced chronic liver disease, presents examples of current best practice and provides pragmatic suggestions for how palliative and disease-modifying care can be run in parallel, such that patients do not miss opportunities for interventions that improve their quality of life.

This record has no associated files available for download.

More information

Accepted/In Press date: 11 August 2019
e-pub ahead of print date: 10 September 2019
Published date: 3 April 2020

Identifiers

Local EPrints ID: 480820
URI: http://eprints.soton.ac.uk/id/eprint/480820
ISSN: 2041-4137
PURE UUID: 38303969-fc09-4aa3-bc62-fdfcde249d8b

Catalogue record

Date deposited: 09 Aug 2023 17:24
Last modified: 17 Mar 2024 02:13

Export record

Altmetrics

Contributors

Author: Hazel Woodland
Author: Ben Hudson
Author: Karen Forbes
Author: Anne McCune
Author: Mark Wright
Corporate Author: British Association for the Study of the Liver (BASL) End of Life Special Interest Group

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×